טוען...
Immunomodulation in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives
The heart failure (HF) epidemic is growing and approximately half of the HF patients have heart failure with preserved ejection fraction (HFpEF). HFpEF is a heterogeneous syndrome, characterized by a preserved left ventricular ejection fraction (LVEF ≥ 50%) with diastolic dysfunction, and is associa...
שמור ב:
| הוצא לאור ב: | J Cardiovasc Transl Res |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer US
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7892675/ https://ncbi.nlm.nih.gov/pubmed/32444946 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12265-020-10026-3 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|